KI
AMED

Kula Investments’s Amedisys AMED Stock Holding History

Kula Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$1.23M Buy
+16,768
New +$1.45M 0.3% 73

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Kula Investments's AMED Position: Q1 2023 in Review

Kula Investments opened a new position in Amedisys (AMED) in Q1 2023: 16,768 shares worth $1.23M. The stake represents 0.3% of the portfolio and ranks #73 among its holdings.

281 funds tracked by Wall St. Rank hold AMED as of Q1 2023.

  • Kula Investments held 16,768 shares of Amedisys worth $1.23M as of Q1 2023.
  • Amedisys was a new Kula Investments position in Q1 2023.
  • Amedisys made up 0.3% of Kula Investments's portfolio in Q1 2023, its #73 holding.
  • 281 funds tracked by Wall St. Rank held Amedisys as of Q1 2023.

Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.